Safety and Outcomes in Infants Born to Mothers Participating in Retosiban Treatment Trials: ARIOS Follow-Up Study.

Marcy Powell,George Saade,Steve Thornton,Jeanne M Pimenta, Nazneen Haque,Diane Miller,Kathleen J Beach,Jerry Snidow, Erika Ochoa Correa,Rhona Scott

American journal of perinatology（2021）

引用 0|浏览1

暂无评分

摘要

· There is a need for an effective and safe treatment for sPTL.. · ARIOS was a follow-up study of two Phase 3 trials in sPTL.. · There were no safety concerns with retosiban treatment.. · Slow recruitment led to termination of the Phase 3 trials..

查看译文

关键词

retosiban,preterm birth,oxytocin receptor antagonists,neurodevelopment

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要